Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic bacteria associated with bacterial vaginosis refer to a diverse mix of **anaerobic and facultative anaerobic bacteria** that cause a shift from the normal, Lactobacillus-dominated vaginal microbiota to a community dominated by **Gardnerella vaginalis, Atopobium vaginae (now Fannyhesaea vaginae), Mobiluncus species, Prevotella species, Megasphaera, Sneathia, and others**[1][2][3][5]. This dysbiotic bacterial community forms polymicrobial biofilms, raises vaginal pH, and degrades protective mucin, making the vaginal environment more susceptible to inflammation and other infections[1][5][7]. The composition is variable between individuals, but the presence and abundance of Gardnerella and Atopobium are particularly associated with diagnosis and recurrence risk. While some bacterial species within this group are targets for antibiotic therapy, the group as a whole does not constitute a single, well-defined drug target, and management is complicated by recurrence and emerging antibiotic resistance[1][7].
Antibacterial (disruption of bacterial cell wall synthesis or function by drugs like metronidazole and clindamycin). Biofilm disruption (emerging therapeutic strategies, not standard drugs).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacteria associated with bacterial vaginosis.